Life-2023-02 Esophagogastric Variceal Bleeding
Recruiting
N/A
Interventional Study
Acute Esophageal Variceal Hemorrhage
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 33 (estimated)
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study on the efficacy of the growth inhibitors after endoscopic treatment of acute esophagogastric variceal bleeding
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* acute esophagogastric bleeding with hepatic cirhosis;
* stable status (no active bleeding)
Exclusion Criteria:
* endoscopic test limitation;
* previous acute esophagogastric bleeding treatment history;
* ICU;
* pregnant;
* Immunity disabled;
Contacts